AzTrials
AzTrials

Carotid Occlusion IntoleranceNCT01922609

Prediction of Carotid Occlusion Intolerance by Transcranial Doppler Evaluation in Patients Undergoing Carotid Artery Stenting With Proximal Flow Arrest Protection System.

An observational study of Carotid Occlusion Intolerance, run by University Hospital, Motol at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this observational pilot study is to determine whether intolerance of carotid occlusion during carotid artery stenting can be predicted with preprocedural transcranial Doppler evaluation. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Carotid Occlusion Intolerance
How many people
30 participants
Where
1 siteCzechia
Study dates
May 2013to Aug 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients with carotid artery stenosis indicated for carotid artery stenting with the use of proximal flow arrest protection device.

Who may be able to join

  • Either >50% symptomatic carotid artery stenosis (transient ischemic attack or ischemic stroke within 6 months before procedure) or >70% asymptomatic carotid artery stenosis eligible for carotid artery stenting with proximal flow arrest protection
  • Signed informed consent

Who cannot join

  • Disagreement to be included in the study
  • Inadequate acoustic window for transcranial Doppler ultrasound monitoring
  • Carotid occlusion
  • Significant extracranial artery stenosis (>50%) other than target artery
  • Inability to hold breath for sufficient time (approximately 30s)

Trial locations and contacts

1 site in 1 country.

Czechia1 site, 1 recruiting
  • Department of Cardiology, University Hospital Motol

    Prague, Czech Republic, 15006

    Miloslav Spacek, MD, 0042022443 ext. 4901, mildaspacek@gmail.com

    Recruiting

Other trials in Czechia

About this study

The aim of this observational pilot study is to determine whether intolerance of carotid occlusion during carotid artery stenting can be predicted with preprocedural transcranial Doppler evaluation.

Read the detailed description

Carotid artery stenting procedures are increasingly performed with devices that involve endovascular clamping of the common carotid artery, thus exposing the ipsilateral hemisphere to hypoperfusion. Approximately 5% of patients do not tolerate the clamp and are in increased risk of periprocedural cerebrovascular complication such as transient ischemic attack or stroke. To date, there is no method available that could be used to predict the risk of occlusion intolerance. The aim of this study is to determine whether preprocedural evaluation with transcranial Doppler ultrasonography can be effective in prediction of occlusion intolerance.

Keywords
Carotid stenting, Proximal protection system, Transcranial Doppler ultrasound, Cerebrovascular reserve

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01922609
Study groupRoleWhat they receive
Normal cerebrovascular reservePatients without preprocedural TCD signs of impaired cerebrovascular reserve
Impaired cerebrovascular reservePatients with preprocedural TCD signs of impaired cerebrovascular reserve

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Carotid occlusion intolerance

    Intolerance of carotid occlusion during carotid artery stenting detected by means of transcranial Doppler evaluation or by clinical signs of occlusion intolerance.

    Measured: During carotid stenting procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2013 (estimated)
  2. Study startMay 2013
  3. Primary completionAug 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01922609
Sponsor's protocol ID
EK-1075/13
Status last verified
Aug 2013
First submitted
11 Aug 2013
Last updated
14 Aug 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Carotid Occlusion Intolerance, run by University Hospital, Motol at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Carotid occlusion intolerance (time frame: During carotid stenting procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in